ASONEP

sonepcizumab (LT1009) · Lpath, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASONEP, covering 2012-01-31 to 2016-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma [Phase 2]